A Dark Vector Cognition product

Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations

125K characters. Original on sec.gov ·

Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations

The 26 tables in Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

Business Overview28
2026 in Summary29
Outlook31
Results of Operations32
Reconciliations of Non-GAAP Financial Measures39
Liquidity and Capital Resources44
Pension Benefits48
Critical Accounting Policies and Estimates50

This Management’s Discussion and Analysis contains “forward-looking statements” within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding business outlook. These forward-looking statements are based on management’s expectations and assumptions as of the date of this Annual Report on Form 10-K and are not guarantees of future performance. Actual performance and financial results may differ materially from projections and estimates expressed in the forward-looking statements because of many factors not anticipated by management. These factors include, without limitation, those described in "Forward-Looking Statements" and Item 1A, Risk Factors, of this Annual Report on Form 10-K.

This discussion should be read together with the consolidated financial statements and related accompanying notes included in this Annual Report on Form 10-K. Financial information is presented on a continuing operations basis.

The financial measures discussed below are presented in accordance with U.S. generally accepted accounting principles ("GAAP"), except as noted. We discuss certain financial measures on an "adjusted", or "non-GAAP", basis, which exclude gains or losses that management does not consider to be representative of our underlying business operations. These adjustments, which are described below for the periods presented, are not reflected in the results of our reportable segments. When viewed together with our GAAP results, we believe these non-GAAP financial measures offer a more complete understanding of the factors and trends affecting our financial performance and support analysis of our results on a more consistent basis. For each non-GAAP financial measure, including adjusted operating income, adjusted operating margin, adjusted earnings per share, adjusted effective tax rate, and capital expenditures, we present a reconciliation to the most directly comparable financial measure calculated in accordance with GAAP. These reconciliations and further explanations of our use of non-GAAP financial measures are presented under “Reconciliations of Non-GAAP Financial Measures”.

Comparisons included in the discussion that follows are for fiscal year 2026 versus ("vs.") fiscal year 2025. A discussion of changes from fiscal year 2024 to fiscal year 2025 and other financial information related to fiscal year 2024 is available in Part II, Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, of our Annual Report on Form 10-K for the fiscal year ended 30 September 2025, which was filed with the SEC on 20 November 2025.

For information concerning activity with our related parties, refer to Note 23, Supplemental Information, to the consolidated financial statements.

BUSINESS OVERVIEW

Air Products and Chemicals, Inc., a Delaware corporation founded in 1940, is a world-leading industrial gases company. Serving energy, environmental, and emerging markets, the Company is generating a cleaner future by providing essential industrial gases, related equipment, and applications expertise that help customers improve productivity, efficiency, and sustainability across a wide range of industries, including energy, chemicals, electronics, metals, manufacturing, food, medical, and space.

We are focused on profitably growing our core industrial gases business by accelerating growth in areas of competitive strength and extending our reach through disciplined opportunities that create long-term value. We develop, engineer, build, own, and operate large-scale hydrogen projects and have extensive capabilities in air separation technology, engineering, and plant operations. Through our sale of equipment businesses, we provide specialized products such as turbomachinery, membrane systems, and cryogenic containers globally. For additional information on our product and service offerings, including production, distribution, and end use, refer to Item 1, Business, of this Annual Report on Form 10-K.

We conduct business in approximately 50 countries and regions throughout the world. Our industrial gases business is organized and operated regionally in the Americas, Asia, Europe, and Middle East and India segments and generates the majority of our sales via our on-site and merchant supply modes. Approximately half our total revenue is generated through the on-site supply mode, which is governed by contracts that are generally long-term in nature with provisions that allow us to pass through changes in energy costs to our customers.

Our Corporate and other segment includes the results of our sale of equipment businesses, costs for corporate support functions and global management activities, and other income and expenses not directly associated with the regional segments, such as foreign exchange gains and losses.

For additional information regarding our supply modes and business segments, refer to Note 5, Revenue Recognition, and Note 24, Business Segment and Geographic Information, to the consolidated financial statements.

2026 IN SUMMARY

In fiscal year 2026, we continued to execute our strategic priorities of improving performance in our core industrial gas business, optimizing our project portfolio, and maintaining disciplined capital allocation. Higher on-site volumes from base business expansion and new assets, favorable currency, pricing, and productivity drove improved underlying results. We also strengthened our backlog, including significant new electronics projects, and advanced the NEOM Green Hydrogen Project through a long-term marketing and distribution agreement with Yara International ASA ("Yara"). At the same time, we decided to exit the Louisiana Clean Energy Complex and certain other clean energy projects and took further actions to exit two coal gasification plants in China, one of which was sold in October 2026. These actions required charges in fiscal year 2026 but are expected to better position the Company over the long term to pursue opportunities with strong commercial support, strategic alignment, and attractive returns.

Key results versus the prior year include:

  • Sales of $13.0 billion increased 8%, or $953.6 million, driven by 4% higher volumes, 2% higher energy cost pass-through, and 2% favorable currency.

  • Operating income of $23.3 million improved 103%, or $900.3 million, from an operating loss of $877.0 million in the prior year, while operating margin improved to a positive 0.2% from a negative 7.3%. Both periods reflect significant charges related to business and asset actions, primarily associated with previously announced project exit decisions.

  • Adjusted operating income of $3.2 billion increased 11%, or $317.5 million, and adjusted operating margin improved to 24.4% from 23.7% in the prior year. The improvement was driven primarily by higher on-site volumes, favorable currency, and higher non-helium pricing, partially offset by higher costs. These non-GAAP results exclude losses resulting from charges for business and asset actions, as well as other items, as described in the "Reconciliations of Non-GAAP Financial Measures" section below.

  • Equity affiliates' income of $745.9 million increased 15%, or $98.2 million, primarily driven by affiliates in the Americas, Middle East and India, and Europe segments.

  • Earnings per share ("EPS") of $2.39 increased $4.13, compared with a loss per share of $1.74 in the prior year. On a non-GAAP basis, adjusted EPS of $13.45 increased 12%, or $1.42, compared to $12.03 in the prior year. A summary table of changes in earnings (loss) per share is presented below.

  • Cash used for investing activities of $4.1 billion decreased 42%, or $3.0 billion, reflecting lower spending on the NEOM Green Hydrogen Project as construction advances toward completion and the impact of certain project cancellations. On a non-GAAP basis, capital expenditures of $3.3 billion decreased 35%, or $1.8 billion.

  • We believe providing a consistent dividend plays a critical part in the creation of shareholder value. During fiscal year 2026, we marked our 44th consecutive year of increasing our dividends and returned approximately $1.6 billion to our shareholders through dividend payments.

Changes in Diluted EPS Attributable to Air Products

Per share data is calculated and presented on a diluted basis in U.S. Dollars per weighted average common share. The per share impacts for the items presented in the table below were calculated independently and may not sum to the total change in diluted EPS due to rounding.

Fiscal Year Ended
30 September
20262025Change vs. Prior Year
Earnings (Loss) per share$2.39($1.77)$4.16
Less: Loss per share from discontinued operations—(0.04)0.04
Earnings (Loss) per share from continuing operations$2.39($1.74)$4.13
% Change from prior year237%
Operating Items
Underlying business:
Volume$1.01
Price, net of variable costs0.12
Other costs(0.20)
Currency0.23
Business and asset actions(A)2.74
Shareholder activism-related costs0.32
Gain on sale of business(0.23)
Gain on sale of other assets(B)(0.11)
Total Operating Items$3.88
Other Items
Equity affiliates:
Equity affiliates' income$0.34
Equity method investment impairment associated with business and asset actions(A)0.01
Interest expense(0.02)
Other non-operating income/expense, net:
Gain on de-designation of cash flow hedges(C)(0.03)
Non-operating expense associated with business and asset actions(A)(0.02)
Non-service pension cost, net0.10
Other non-operating0.02
Change in effective tax rate, excluding discrete items below0.04
Tax reform adjustment related to deemed foreign dividends(0.22)
Tax on repatriation of foreign earnings0.14
Noncontrolling interests (A)(C)(0.11)
Total Other Items$0.25
Total Change$4.13
% Change from prior year237%

(A)Per share impacts were calculated based on total after-tax charges for business and asset actions attributable to Air Products of $2.4 billion and $3.0 billion for fiscal years 2026 and 2025, respectively, with $40.3 million and $10.7 million attributable to noncontrolling partners.

(B)Reflected on the consolidated income statements within "Other income (expense), net."

(C)Per share impact reflected within "Gain on de-designation of cash flow hedges" was calculated based on an after-tax gain attributable to Air Products of $7.2 million in fiscal year 2025. The gain attributable to our noncontrolling partners was $17.6 million.

The table below summarizes the per share impact of our non-GAAP adjustments for fiscal years 2026 and 2025. These impacts were calculated independently and may not sum to totals due to rounding.

Fiscal Year Ended 30 September20262025Change vs. Prior Year
Earnings (Loss) per Share$2.39($1.74)$4.13
Business and asset actions10.9513.68(2.73)
Shareholder activism-related costs—0.32(0.32)
Gain on sale of business—(0.23)0.23
Gain on sale of other assets—(0.11)0.11
Gain on de-designation of cash flow hedges—(0.03)0.03
Non-service pension cost, net0.050.15(0.10)
Tax reform adjustment related to deemed foreign dividends0.06(0.16)0.22
Tax on repatriation of foreign earnings—0.14(0.14)
Adjusted Earnings per Share$13.45$12.03$1.42
% Change from prior year12%

OUTLOOK

Statements regarding business outlook should be read in conjunction with the Forward-Looking Statements of this Annual Report on Form 10-K.

As we begin the new year, we remain focused on profitably growing our core industrial gases business and deploying capital in a disciplined manner.

For fiscal year 2027, we expect earnings growth supported by contributions from new assets, pricing and productivity actions that offset inflation, and modest volume growth from our existing assets.

From a cash flow and capital allocation perspective, we expect to continue investing in our traditional industrial gas backlog while progressing our remaining energy transition projects toward completion. We will continue to prioritize investments with strong commercial support that meet our risk-adjusted return requirements. We also remain focused on strengthening our balance sheet while maintaining our longstanding commitment to returning value to shareholders through dividends.

RESULTS OF OPERATIONS

DISCUSSION OF CONSOLIDATED RESULTS

Change vs. Prior Year
Fiscal Year Ended 30 September (Millions of U.S. Dollars)20262025$%/bp
GAAP Measures
Sales$12,990.9$12,037.3$953.68%
Operating income (loss)23.3(877.0)900.3103%
Operating margin0.2%(7.3%)750 bp
Equity affiliates’ income$745.9$647.7$98.215%
Non-GAAP Measures
Adjusted operating income$3,175.2$2,857.7$317.511%
Adjusted operating margin24.4%23.7%70bp

Sales

The table below summarizes the major factors that impacted consolidated sales for the periods presented:

Volume4%
Price—%
Energy cost pass-through2%
Currency2%
Total Consolidated Sales Change8%

Sales of $13.0 billion increased 8%, or $953.6 million, due to higher volumes of 4%, higher energy cost pass-through of 2%, and favorable currency impacts of 2%. Volume growth was driven by on-sites, primarily from a significant asset sale associated with an early contract termination in the Americas segment, HyCO facilities, and new assets. The asset sale was structured as a financing arrangement that includes payments through April 2035. These benefits were partially offset by favorable non-recurring items in the prior year, including a significant helium sale to an existing merchant customer and a one-time customer contract amendment in the Americas segment. Currency was favorable as the U.S. Dollar weakened, most notably against the Chinese Renminbi and Euro. Higher energy cost pass-through reflects higher natural gas rates compared to fiscal year 2025, primarily in the Americas and Europe segments. Pricing was flat as improvement across non-helium product lines was offset by lower helium pricing.

Cost of Sales and Gross Margin

Cost of sales of $8.9 billion increased 8%, or $631.8 million, primarily due to higher costs attributable to sales volumes of $209 million, largely driven by the asset sale in the Americas, higher energy cost pass-through of $177 million, and unfavorable currency impacts of $167 million. Other unfavorable costs of $63 million were primarily due to fixed-cost inflation and higher incentive compensation, partially offset by lower depreciation expense. Higher variable costs of $16 million were driven by higher power costs, partially offset by lower product sourcing costs. Gross margin of 31.6% increased 20 bp from 31.4% in the prior year driven by higher volumes, partially offset by higher costs and energy cost pass-through.

Selling and Administrative Expense

Selling and administrative expense of $903.2 million decreased $2.9 million, with expense as a percentage of sales improving 50 bp to 7.0%. This primarily reflects productivity improvements that more than offset fixed-cost inflation, higher incentive compensation, and unfavorable currency impacts.

Research and Development Expense

Research and development expense of $88.9 million decreased 8%, or $7.4 million. Research and development expense as a percentage of sales decreased to 0.7% from 0.8% in the prior year.

Business and Asset Actions

During fiscal year 2026, the Company recognized business and asset actions charges of approximately $3.2 billion pre-tax ($2.4 billion attributable to Air Products after tax, or $10.95 per share). These charges primarily related to project exit decisions announced in the third quarter and further actions taken to exit two coal gasification plants in China, one of which was sold in October 2026. During fiscal year 2025, charges of approximately $3.7 billion pre-tax ($3.0 billion attributable to Air Products after tax, or $13.68 per share) related to project exit decisions approved in the second quarter of fiscal year 2025 and separation costs associated with our global cost reduction plan. Charges for business and asset actions are not reflected in the results of our reportable segments. For additional information, refer to Note 4, Business and Asset Actions, to the consolidated financial statements.

Shareholder Activism-Related Costs

During fiscal year 2025, costs of $86.3 million pre-tax ($71.7 million after tax, or $0.32 per share) were recorded in connection with a proxy contest that concluded in January 2025 following certification of the directors elected at the 2025 Annual Meeting of Shareholders. These costs were not reflected in the results of our reportable segments. For additional information, refer to Note 23, Supplemental Information, to the consolidated financial statements.

Gain on Sale of Business

In fiscal year 2025, we recognized a gain of $67.3 million pre-tax ($51.9 million after tax, or $0.23 per share) on the sale of our 100% ownership interest in a consolidated subsidiary in Singapore. This gain was not reflected in the results of the Asia segment. Refer to Note 6, Gain on Sale of Business, to the consolidated financial statements for additional information.

Other Income (Expense), Net

Other income of $64.2 million decreased 42%, or $45.9 million, primarily due to a prior-year gain of $31.3 million pre-tax ($23.8 million after tax, or $0.11 per share) on the sale of a regional office in Hersham, England, which was not reflected in the results of the Europe segment.

Operating Income (Loss) and Operating Margin

Operating income of $23.3 million improved 103%, or $900.3 million, from an operating loss of $877.0 million in the prior year. Both periods included significant business and asset action charges, which totaled approximately $3.2 billion pre-tax ($2.4 billion attributable to Air Products after tax, or $10.95 per share) in fiscal year 2026 compared to $3.7 billion ($3.0 billion attributable to Air Products after tax, or $13.68 per share) in fiscal year 2025. Additionally, the prior year included pre-tax gains totaling approximately $99 million in connection with the sale of a consolidated subsidiary and a regional office, partially offset by shareholder activism-related costs of $86 million.

Volume impacts were favorable by $276 million driven primarily by on-site, including new assets and HyCO facilities. The current year also benefited from a significant asset sale associated with an early contract termination, which was more than offset by favorable non-recurring items in the prior year, including a one-time customer contract amendment and a significant helium sale to an existing merchant customer. Each of these items related to the Americas segment. Currency was favorable by $63 million, and pricing, net of power costs, improved $34 million driven by non-helium merchant products. Costs were unfavorable by $55 million, as fixed-cost inflation and higher incentive compensation were partially offset by productivity improvements and lower depreciation expense.

Operating margin of 0.2% improved 750 bp from a negative operating margin of 7.3% in the prior year. The improvement primarily reflects lower charges for business and asset actions.

On a non-GAAP basis, which excludes the charges for business and asset actions, prior-year sales of businesses and other assets, and prior-year shareholder activism-related costs, adjusted operating income of $3.2 billion increased 11%, or $317.5 million, primarily due to higher on-site volumes, favorable currency, and higher non-helium pricing. These benefits were partially offset by higher costs. Adjusted operating margin improved 70 bp to 24.4% from 23.7% in the prior year, primarily due to higher volumes, partially offset by higher costs and energy cost pass-through.

Equity Affiliates’ Income

Equity affiliates' income of $745.9 million increased 15%, or $98.2 million, primarily driven by affiliates in the Americas, Middle East and India, and Europe segments.

Interest Expense

Fiscal Year Ended 30 September (Millions of U.S. Dollars)20262025
Interest incurred$674.8$615.8
Less: Capitalized interest454.4401.8
Interest expense$220.4$214.0

Interest expense increased 3%, or $6.4 million, driven by higher interest incurred on principal borrowings from Euro- and U.S. Dollar-denominated senior fixed-rate notes issued in fiscal year 2025, partially offset by an increase in capitalized interest due to a higher carrying value of projects under construction.

Other Non-Operating Income (Expense), Net

Other non-operating income of $3.2 million increased 23%, or $0.6 million. Favorable impacts from lower non-service pension costs and higher income from excluded components from the assessment of effectiveness of our derivatives were partially offset by lower interest income on cash equivalents and short-term investments. The prior year also included a gain on certain interest rate swaps held by the NEOM Green Hydrogen Company joint venture. Refer to Note 3, Variable Interest Entities, to the consolidated financial statements for additional information.

Effective Tax Rate

The effective tax rate equals the income tax expense (benefit) divided by income (loss) before taxes. Equity affiliates' income is primarily included net of income taxes within income (loss) before taxes on our consolidated income statements. The table below outlines the calculation of the effective tax rate for fiscal years ended 30 September:

(Millions of U.S. Dollars; rates stated as a percentage of income before taxes)20262025
Income tax expense (benefit)$1.6($94.3)
Income (loss) from continuing operations before taxes552.0(440.7)
Effective tax rate0.3%21.4%

As discussed in Note 4, Business and Asset Actions, to the consolidated financial statements, we recorded charges for business and asset actions, primarily related to project exit decisions, that contributed to significant variability in our effective tax rate for the periods presented. During fiscal year 2026, we recognized net tax benefits of $680.3 million associated with these charges, primarily reflecting tax benefits recognized at statutory income tax rates in the U.S. Included in the fiscal year 2026 net tax benefit were $56.3 million of foreign income tax costs related to valuation allowances and tax costs on the outside basis difference in subsidiaries. In the prior year, a net tax benefit of $695.2 million was recognized primarily during the second quarter. The net tax benefit in fiscal year 2025 included an $11.3 million cost for an uncertain tax position reserve and a net tax cost of $197.4 million due to valuation allowances on deferred tax assets related to the future disposal of certain foreign subsidiaries. For additional information, refer to Note 22, Income Taxes, to the consolidated financial statements.

The current-year rate was also lower due to earning a greater share of income in jurisdictions with lower tax rates, increased income from equity affiliates, and higher foreign and domestic tax credits and incentives. These decreases were partially offset by a higher cost of U.S. tax on foreign earnings in the current year, larger excess tax benefits on share-based compensation in the prior year, and a prior-year benefit from a U.S. state tax law change. The prior year also included a net tax benefit for a U.S. Tax Cuts and Jobs Act refund claim, compared to a decrease in the expected benefit in the current fiscal year.

Our adjusted effective tax rate, which excludes the impact of project exit costs and other adjustments described in the "Reconciliations of Non-GAAP Financial Measures" section, was 18.0% and 18.2% for fiscal years 2026 and 2025, respectively. A reconciliation of the adjusted measures to the effective tax rate calculated in accordance with GAAP is provided on page 42.

Loss from Discontinued Operations

In fiscal year 2025, we recorded a pre-tax loss from discontinued operations of $10.6 million ($8.0 million after tax, or $0.04 per share) primarily to increase existing liabilities for retained environmental remediation obligations associated with businesses sold in 2008. Refer to the "Piedmont" discussion under Note 17, Commitments and Contingencies, for additional information. The loss did not result in cash flows from discontinued operations.

DISCUSSION OF RESULTS BY BUSINESS SEGMENT

Americas

Change vs. Prior Year
Fiscal Year Ended 30 September (Millions of U.S. Dollars)20262025$%/bp
Sales$5,681.7$5,125.9$555.811%
Operating income1,642.21,519.6122.68%
Operating margin28.9%29.6%(70 bp)
Equity affiliates’ income$218.3$157.0$61.339%

The table below summarizes the major factors that impacted sales in the Americas segment for the periods presented:

Volume8%
Price1%
Energy cost pass-through2%
Currency—%
Total Americas Sales Change11%

Sales of $5.7 billion increased 11%, or $555.8 million, due to higher volumes of 8%, higher energy cost pass-through of 2%, and higher pricing of 1%. Volume growth was driven by on-sites, including a significant asset sale associated with an early contract termination, higher volumes from HyCO facilities, and a new asset contribution. The asset sale was structured as a financing arrangement that includes payments through April 2035. These benefits were partially offset by favorable non-recurring items in the prior year, including a significant helium sale to an existing merchant customer and a one-time customer contract amendment. Higher energy cost pass-through reflects higher natural gas rates compared to fiscal year 2025. Pricing improvements across non-helium product lines were partially offset by lower helium pricing.

Operating income of $1.6 billion increased 8%, or $122.6 million, as higher volumes of $144 million, higher pricing, net of power costs, of $20 million, and favorable currency of $7 million were partially offset by higher costs of $48 million. Higher costs were primarily driven by fixed-cost inflation, increased incentive compensation, and higher product distribution and dislocation costs, partially offset by lower depreciation expense. Operating margin of 28.9% decreased 70 bp from 29.6% in the prior year, primarily due to increased costs and higher energy cost pass-through, partially offset by volume growth. The headwind from higher energy cost pass-through was approximately 50 bp.

Equity affiliates’ income of $218.3 million increased 39%, or $61.3 million, driven by higher volumes under a short-term contract at an affiliate in Mexico.

Asia

Change vs. Prior Year
Fiscal Year Ended 30 September (Millions of U.S. Dollars)20262025$%/bp
Sales$3,458.7$3,271.0$187.76%
Operating income978.9851.1127.815%
Operating margin28.3%26.0%230 bp
Equity affiliates’ income$45.5$42.3$3.28%

The table below summarizes the major factors that impacted sales in the Asia segment for the periods presented:

Volume3%
Price(1%)
Energy cost pass-through1%
Currency3%
Total Asia Sales Change6%

Sales of $3.5 billion increased 6%, or $187.7 million, as higher volumes of 3%, favorable currency of 3%, and higher energy cost pass-through of 1% were partially offset by lower pricing of 1%. Volume growth was driven by on-sites, including contributions from new assets, as well as helium. Favorable currency was primarily attributable to the weakening of the U.S. Dollar against the Chinese Renminbi. The decline in pricing was broad-based across merchant product lines, including helium.

Operating income of $978.9 million increased 15%, or $127.8 million, as higher volumes of $111 million, favorable currency impacts of $22 million, and lower costs of $17 million were partially offset by lower pricing, net of power costs, of $22 million. Operating margin of 28.3% increased 230 bp from 26.0% in the prior year, primarily reflecting volume growth and favorable costs, partially offset by lower pricing. Depreciation expense was lower in fiscal year 2026, primarily due to the classification of certain gasification assets as held for sale.

Equity affiliates’ income of $45.5 million increased 8%, or $3.2 million, driven primarily by affiliates in China and Thailand.

Europe

Change vs. Prior Year
Fiscal Year Ended 30 September (Millions of U.S. Dollars)20262025$%/bp
Sales$3,242.2$2,984.5$257.79%
Operating income906.9844.762.27%
Operating margin28.0%28.3%(30 bp)
Equity affiliates’ income$120.1$101.9$18.218%

The table below summarizes the major factors that impacted sales in the Europe segment for the periods presented:

Volume1%
Price1%
Energy cost pass-through2%
Currency5%
Total Europe Sales Change9%

Sales of $3.2 billion increased 9%, or $257.7 million, due to favorable currency of 5%, higher energy cost pass-through of 2%, higher volumes of 1%, and higher pricing of 1%. Favorable currency primarily reflected the weakening of the U.S. Dollar against the Euro. Higher energy cost pass-through reflects higher natural gas rates compared to fiscal year 2025. Volume growth reflected favorable on-sites, including the impact of a prior-year turnaround, and higher merchant volumes, partially offset by weaker helium. Pricing improvements across non-helium product lines were partially offset by lower helium pricing.

Operating income of $906.9 million increased 7%, or $62.2 million, due to volume growth of $50 million, favorable currency of $30 million, and higher pricing, net of lower power costs, of $30 million. These benefits were partially offset by higher costs of $48 million driven by fixed-cost inflation and higher depreciation expense. Operating margin of 28.0% decreased 30 bp from 28.3% in the prior year primarily due to higher costs and an approximately 50 bp headwind from higher energy cost pass-through, partially offset by volume growth and pricing.

Equity affiliates’ income of $120.1 million increased 18%, or $18.2 million, driven primarily by an affiliate in Italy.

Middle East and India

Change vs. Prior Year
Fiscal Year Ended 30 September (Millions of U.S. Dollars)20262025$%
Sales$129.1$135.9($6.8)(5%)
Operating income22.19.612.5130%
Equity affiliates’ income362.0340.921.16%

Sales of $129.1 million decreased 5%, or $6.8 million, due to lower volumes and unfavorable impact from currency, partially offset by higher pricing. Operating income of $22.1 million improved from $9.6 million in the prior year, primarily due to lower costs from productivity improvements and the fiscal year 2025 deconsolidation of the Blue Hydrogen Industrial Gases Company ("BHIG") joint venture in Saudi Arabia.

Equity affiliates' income of $362.0 million increased 6%, or $21.1 million, driven primarily by an affiliate in Saudi Arabia.

Corporate and other

Change vs. Prior Year
Fiscal Year Ended 30 September (Millions of U.S. Dollars)20262025$%
Sales$479.2$520.0($40.8)(8%)
Operating loss(374.9)(367.3)(7.6)(2%)
Equity affiliates' income2.012.4(10.4)(84%)

Sales of $479.2 million decreased 8%, or $40.8 million, primarily due to lower equipment volumes. Operating loss of $374.9 million increased 2%, or $7.6 million. The impact on operating loss was partially offset by lower changes in cost estimates on certain sale of equipment projects and productivity improvements.

Equity affiliates' income of $2.0 million decreased 84%, or $10.4 million, driven primarily by an affiliate in Algeria.

RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES

(Millions of U.S. Dollars unless otherwise indicated, except for per share data)

We present certain financial measures that are not calculated in accordance with U.S. generally accepted accounting principles ("GAAP") because they exclude items that management does not consider to be representative of our underlying business operations. We provide these adjusted non-GAAP financial measures to allow investors, potential investors, securities analysts, and others to evaluate our business in the same manner as management. When viewed together with our GAAP results, we believe these non-GAAP financial measures offer a more complete understanding of the factors and trends affecting our financial performance and support analysis of our results on a more consistent basis.

Readers are cautioned that non‑GAAP financial measures have inherent limitations and should not be considered in isolation or as a substitute for the corresponding GAAP measures. Our definitions and calculations of non‑GAAP financial measures may differ from those used by other companies, which may limit comparability.

Non-GAAP Performance Measures

Management uses non-GAAP performance measures, including adjusted operating income, adjusted operating margin, and adjusted earnings per share ("EPS"), to assess our performance because these measures exclude items that management does not consider to be representative of our underlying business operations. In addition, adjusted operating income and adjusted EPS are important components of our incentive compensation plans. We also use adjusted operating margin to assess operational efficiency, cost discipline, and overall profitability.

Our non‑GAAP performance measures are adjusted to exclude gains or losses that management believes are not associated with the ongoing operations of our business. These adjustments, which are described below for the periods presented, are not reflected in the results of our reportable segments. Although these items are often difficult to predict, readers should be aware that similar gains or losses may occur in future periods. The related tax effects reflect the expected current and deferred income tax impacts of our non-GAAP adjustments, which are primarily driven by the statutory tax rates of the applicable jurisdictions and the taxability of the underlying adjustments in those jurisdictions.

We reconcile each non‑GAAP performance measure to its most directly comparable GAAP measure in the table below, followed by descriptions of each non-GAAP adjustment. Amounts presented in the reconciliation are in millions of U.S. Dollars, except for per share data. Margins are calculated by dividing the applicable line item by consolidated sales for the relevant period.

In addition to our non-GAAP performance measures, we also present components used in calculating adjusted EPS to illustrate the per share effect of our non‑GAAP adjustments. All per share amounts are calculated on a diluted basis from continuing operations attributable to Air Products. Because margins and per share amounts are calculated independently, the individual components may not sum to the related totals due to rounding.

FY2026 vs. FY2025Operating Income/LossOperating MarginEquity Affiliates' IncomeOther Non- Operating Inc/Exp, NetIncome Tax Expense/BenefitNet Income/Loss Attributable to Air ProductsEarnings/ Loss per Share
FY2026 GAAP Measures$23.30.2%$745.9$3.2$1.6$532.1$2.39
FY2025 GAAP Measures(877.0)(7.3%)647.72.6(94.3)(386.5)(1.74)
$ GAAP Change$900.3$4.13
%/bp GAAP Change103%750 bp237%
FY2026 GAAP Measures$23.30.2%$745.9$3.2$1.6$532.1$2.39
Business and asset actions(A)3,151.924.3%2.06.3680.32,439.610.95
Non-service pension cost, net——%—15.74.011.70.05
Tax reform adjustment related to deemed foreign dividends——%——(14.2)14.20.06
FY2026 Adjusted Measures$3,175.224.4%$747.9$25.2$671.7$2,997.6$13.45
FY2025 GAAP Measures($877.0)(7.3%)$647.7$2.6($94.3)($386.5)($1.74)
Business and asset actions(A)3,747.031.1%6.8—695.23,047.913.68
Shareholder activism-related costs86.30.7%——14.671.70.32
Gain on sale of business(67.3)(0.6%)——(15.4)(51.9)(0.23)
Gain on sale of other assets(B)(31.3)(0.3%)——(7.5)(23.8)(0.11)
Gain on de-designation of cash flow hedges(C)——%—(27.0)(2.2)(7.2)(0.03)
Non-service pension cost, net——%—45.011.333.70.15
Tax reform adjustment related to deemed foreign dividends——%——34.9(34.9)(0.16)
Tax on repatriation of foreign earnings——%——(31.4)31.40.14
FY2025 Adjusted Measures$2,857.723.7%$654.5$20.6$605.2$2,680.4$12.03
$ Adjusted Change$317.5$1.42
%/bp Adjusted Change11%70 bp12%

(A) Charge attributable to noncontrolling interests was $40.3 million and $10.7 million for fiscal years 2026 and 2025, respectively.

(B) Reflected on the fiscal year 2025 consolidated income statement in "Other income (expense), net."

(C) Gain attributable to noncontrolling interests was $17.6 million in fiscal year 2025.

NON-GAAP ADJUSTMENTS

Business and Asset Actions

During fiscal year 2026, we recorded pre-tax charges of approximately $3.2 billion ($2.4 billion attributable to Air Products after tax, or $10.95 per share). These charges primarily related to project exit actions announced on 30 June 2026, including the exit of a clean energy complex under construction in Louisiana, a green hydrogen production facility under construction in Casa Grande, Arizona, and certain other clean energy projects. Full-year charges attributable to noncontrolling interests were $40.3 million.

Included in the fiscal year 2026 charges were $224.5 million pre-tax ($203.0 million after tax, or $0.91 per share) recorded during the fourth quarter, primarily to update the carrying value of two coal gasification plants in China that were previously impaired and classified as held for sale. The charges reflected updated estimates of fair value less costs to sell based on information obtained through the marketing process. We fully impaired the remaining assets of one plant due to limited buyer interest, while the carrying value of the other plant was updated to reflect the terms of a sales agreement. The plant subject to the sales agreement was subsequently sold in October 2026. Fourth quarter charges attributable to noncontrolling interests were $39.7 million.

During fiscal year 2025, we recorded pre-tax charges of approximately $3.7 billion ($3.0 billion attributable to Air Products after tax, or $13.68 per share), including $795.0 million ($741.9 million attributable to Air Products after tax, or $3.33 per share) recorded during the fourth quarter. These charges reflected costs associated with project exits, including certain clean-energy generation and distribution projects and the initial impairment of the two China coal gasification plants, as well as separation costs in connection with our global cost reduction plan. Charges attributable to noncontrolling interests were $10.7 million for fiscal year 2025, including $7.2 million recorded during the fourth quarter.

For additional information, refer to Note 4, Business and Asset Actions, to the consolidated financial statements.

Estimates related to business and asset actions reflect management's best judgment based on information available at the time the charges were recorded. Final settlement may differ materially from these estimates and could impact our consolidated financial statements in future periods.

Non-Service Related Pension Items

Non-service related pension items resulted in net non-operating costs of $15.7 million ($11.7 million after tax, or $0.05 per share) in fiscal year 2026 compared to $45.0 million ($33.7 million after tax, or $0.15 per share) in fiscal year 2025. Non-service related components are recurring, non-operating items that include interest cost, expected return on plan assets, prior service cost amortization, actuarial loss amortization, as well as special termination benefits, curtailments, and settlements. The net impact of non-service related components is reflected within “Other non-operating income (expense), net” on our consolidated income statements. Adjusting for the impact of non-service pension components provides management and users of our financial statements with a more accurate representation of our underlying business performance because these components are driven by factors that are unrelated to our operations, such as volatility in equity and debt markets. Further, non-service related components are not indicative of our defined benefit plans’ future contribution needs due to the funded status of the plans.

Tax Reform Adjustment Related to Deemed Foreign Dividends

During the second quarter of fiscal year 2025, we recorded a net income tax benefit of $34.9 million ($0.16 per share) related to our intent to file a refund claim for the 2018 tax year. Our intent to pursue the refund claim was based on a review of several U.S. Tax Court cases regarding the U.S. taxation of deemed foreign dividends in the transition year of the U.S. Tax Cuts and Jobs Act. The benefit was net of a $67.8 million liability for an uncertain tax position.

In September 2026, a subsequent U.S. Tax Court decision provided additional guidance regarding the calculation of the refund amount. As a result, we recorded income tax expense of $14.2 million ($0.06 per share) during the fourth quarter of fiscal year 2026 to increase the related liability for an uncertain tax position.

Other Fiscal Year 2025 Adjustments

The following adjustments impacted fiscal year 2025 results only.

Shareholder Activism-Related Costs

We incurred shareholder activism-related costs in fiscal year 2025 associated with a proxy contest that concluded in January 2025 following the certification of director election results at the 2025 Annual Meeting of Shareholders. Total pre-tax costs of $86.3 million ($71.7 million after tax, or $0.32 per share) were recognized during the first three quarters of fiscal year 2025. No shareholder activism-related costs were incurred in the fourth quarter.

Gain on Sale of Business

In April 2025, we completed the sale of our 100% ownership interest in a consolidated subsidiary in Singapore for cash proceeds of $104.3 million. We recognized a gain of $67.3 million pre-tax ($51.9 million after-tax, or $0.23 per share) as a result of the transaction during the third quarter of fiscal year 2025.

Gain on Sale of Other Assets

In June 2025, we sold a regional office in Hersham, England, for cash proceeds of $37.7 million. We recognized a gain on sale of $31.3 million pre-tax ($23.8 million after-tax, or $0.11 per share) during the third quarter of fiscal year 2025 that is presented within “Other income (expense), net” on our consolidated income statements.

Gain on De-designation of Cash Flow Hedges

In fiscal year 2024, we discontinued cash flow hedge accounting for certain interest rate swaps due to changes in the anticipated drawdown timeline for hedged borrowings related to the NEOM Green Hydrogen Project. These swaps are held by NEOM Green Hydrogen Company, a consolidated joint venture accounted for under the variable interest model, in which Air Products holds a one-third ownership interest. As a result of the de-designation, unrealized gains and losses related to the affected swaps were recorded in "Other non-operating income (expense), net" on our consolidated income statements. During fiscal year 2025, we recorded a net unrealized gain of $27.0 million pre-tax ($7.2 million attributable to Air Products after tax, or $0.03 per share), with $17.6 million attributable to our noncontrolling partners.

We re-designated the affected swaps as cash flow hedges when the outstanding borrowings under the available project financing became commensurate with the swaps’ notional values. As of 1 January 2026, all swaps were re-designated as cash flow hedges. The unrealized gain on swaps that remained de-designated during the first quarter of fiscal year 2026 was not material.

Tax on Repatriation of Foreign Earnings

During the second quarter of fiscal year 2025, we recorded an income tax expense of $31.4 million ($0.14 per share) related to estimated withholding taxes on foreign earnings that we no longer intended to indefinitely reinvest.

Loss From Discontinued Operations

Our non-GAAP financial measures are presented on a continuing operations basis, which excludes a pre-tax loss from discontinued operations of $10.6 million ($8.0 million after tax, or $0.04 per share) recorded during the third quarter of fiscal year 2025 primarily to increase retained environmental remediation obligations associated with businesses sold in 2008.

ADJUSTED EFFECTIVE TAX RATE

The effective tax rate equals the income tax expense (benefit) divided by income (loss) from continuing operations before taxes. We calculate our adjusted effective tax rate by adjusting the numerator and denominator to exclude the tax and before tax impacts of our non-GAAP adjustments, respectively. The table below presents a reconciliation of the GAAP effective tax rate to our adjusted effective tax rate for the fiscal years ended 30 September:

(Millions of U.S. Dollars; rates stated as a percentage of income before taxes)20262025
Income tax expense (benefit)$1.6($94.3)
Income (loss) from continuing operations before taxes552.0(440.7)
Effective tax rate0.3%21.4%
Reconciliations of GAAP to Non-GAAP:
Income tax expense (benefit)$1.6($94.3)
Business and asset actions tax impact680.3695.2
Shareholder activism-related costs tax impact—14.6
Gain on sale of business tax impact—(15.4)
Gain on sale of other assets tax impact—(7.5)
Gain on de-designation of cash flow hedges tax impact—(2.2)
Non-service pension cost, net tax impact4.011.3
Tax reform adjustment related to deemed foreign dividends(14.2)34.9
Tax on repatriation of foreign earnings—(31.4)
Adjusted income tax expense$671.7$605.2
Income (loss) from continuing operations before taxes$552.0($440.7)
Business and asset actions(A)3,160.23,753.8
Shareholder activism-related costs—86.3
Gain on sale of business—(67.3)
Gain on sale of other assets—(31.3)
Gain on de-designation of cash flow hedges—(27.0)
Non-service pension cost, net15.745.0
Adjusted income from continuing operations before taxes$3,727.9$3,318.8
Adjusted effective tax rate18.0%18.2%

(A) Includes equity affiliates’ losses of $2.0 million and $6.8 million in fiscal years 2026 and 2025, respectively. Fiscal year 2026 also includes $6.3 million of other non-operating expense.

CAPITAL EXPENDITURES

Capital expenditures is a non-GAAP financial measure that management uses to evaluate our deployment of capital and assess alignment with our strategic priorities. Our calculation of this measure begins as the sum of cash paid for additions to plant and equipment, including long-term deposits, acquisitions (less cash acquired), investment in and advances to unconsolidated affiliates, and investment in financing receivables, each of which are reported on our consolidated statements of cash flows.

We then adjust this amount to exclude spending for additions to plant and equipment by our consolidated joint venture, NEOM Green Hydrogen Company (“NGHC”), to the extent such spending is funded by sources other than Air Products’ cash. These other funding sources include NGHC’s project financing, which is non‑recourse to Air Products, as well as equity contributions from the other joint venture partners. Management believes this adjustment provides a more useful view of the capital we deploy to support the ongoing growth of our business.

Fiscal Year Ended 30 September (Millions of U.S. Dollars)20262025
Cash used for investing activities$4,146.0$7,168.7
Proceeds from sale of assets and investments153.2245.8
Purchases of short-term investments—(117.6)
Proceeds from short-term investments—122.5
Proceeds from other investing activities31.5115.4
NGHC expenditures not funded by Air Products' equity(A)(1,024.9)(2,470.7)
Capital expenditures$3,305.8$5,064.1

(A)Reflects the portion of "Additions to plant and equipment, including long-term deposits" that is associated with NGHC, less our approximate cash investment in the joint venture. Substantially all the funding we provide to NGHC is limited for use by the joint venture for its capital expenditures.

LIQUIDITY AND CAPITAL RESOURCES

We believe we have sufficient cash, cash flows from operations, and access to funding sources to meet our liquidity needs. As discussed in "Cash Flows From Financing Activities", we are able to raise capital through a variety of financing activities, including accessing capital or commercial paper markets or drawing upon our credit facilities.

As of 30 September 2026, we held cash and cash items of $1.3 billion, of which $968.3 million was held outside the U.S. We do not expect a significant portion of the earnings from our foreign subsidiaries and affiliates to be subject to U.S. income tax upon repatriation. Depending on the country in which these entities operate, repatriation of earnings may be subject to foreign withholding and other taxes. However, we intend to indefinitely reinvest the majority of our foreign cash and cash items that would be subject to additional taxes outside the U.S.

Cash Flows From Operations

Fiscal Year Ended 30 September (Millions of U.S. Dollars)20262025
Net income (loss) from continuing operations attributable to Air Products$532.1($386.5)
Adjustments to reconcile net income (loss) to cash provided by operating activities:
Depreciation and amortization1,521.91,564.2
Deferred income taxes(456.1)(554.8)
Tax reform adjustment related to deemed foreign dividends14.2(34.9)
Gain on sale of business—(67.3)
Business and asset actions3,151.93,747.0
Undistributed earnings of equity method investments(197.1)(269.8)
Gain on sale of assets and investments(19.7)(66.4)
Share-based compensation50.476.4
Noncurrent lease receivables49.052.5
Other adjustments136.848.0
Changes in working capital accounts(102.7)(851.6)
Cash Provided by Operating Activities$4,680.7$3,256.8

In fiscal year 2026, cash provided by operating activities was $4.7 billion. Charges for business and asset actions totaled $3.2 billion, primarily driven by project exit costs as described in Note 4, Business and Asset Actions, to the consolidated financial statements. The adjustment for deferred income taxes of $456.1 million was largely attributable to tax deductions associated with these costs, partially offset by tax benefits realized in fiscal year 2026 that related to charges in the prior year.

Working capital changes in fiscal year 2026 resulted in a net use of cash of $102.7 million. A use of cash of $236.7 million related to payables and accrued liabilities was primarily due to payments for contract terminations associated with our business and asset actions, incentive compensation under the fiscal year 2025 plan, and severance costs previously accrued under our global cost reduction plan. Partially offsetting these uses, other working capital provided cash of $87.5 million, primarily reflecting customer collections related to our sale of equipment projects.

In fiscal year 2025, cash provided by operating activities was $3.3 billion. Charges for business and asset actions totaled $3.7 billion, primarily driven by project exit costs. The adjustment for deferred income taxes of $554.8 million was largely attributable to tax deductions associated with these costs.

Working capital changes in fiscal year 2025 resulted in a net use of cash of $851.6 million. Other working capital used cash of $562.6 million driven by accrued income taxes. In fiscal year 2025, we made approximately $395 million in tax payments related to the 2024 sale of the LNG business. Payables and accrued liabilities were a use of cash of $224.0 million, primarily due to payments for contract terminations associated with our business and asset actions and previously accrued severance actions under our global cost reduction plan.

Cash Flows From Investing Activities

Fiscal Year Ended 30 September (Millions of U.S. Dollars)20262025
Additions to plant and equipment, including long-term deposits($4,203.9)($7,022.6)
Acquisitions, less cash acquired—(59.9)
Investments in and advances to unconsolidated affiliates(126.8)(390.4)
Investments in financing receivables—(61.9)
Proceeds from sale of assets and investments153.2245.8
Purchases of short-term investments—(117.6)
Proceeds from short-term investments—122.5
Proceeds from other investing activities31.5115.4
Cash Used for Investing Activities($4,146.0)($7,168.7)

In fiscal year 2026, cash used for investing activities was $4.1 billion, primarily driven by additions to plant and equipment, including long-term deposits. These additions were lower than the prior year, reflecting lower spending on the NEOM Green Hydrogen Project as construction advances toward completion and the impact of certain project cancellations. NEOM-related additions totaled $1.3 billion. Investments in and advances to unconsolidated affiliates of $126.8 million related to BHIG. Partially offsetting these uses were cash proceeds from sales of assets and investments of $153.2 million, which included approximately $100 million from asset disposals associated with business and asset actions.

In fiscal year 2025, cash used for investing activities was $7.2 billion, primarily driven by additions to plant and equipment, including long-term deposits. These additions included $3.0 billion related to the NEOM Green Hydrogen Project. Other uses of cash included $390.4 million for investments in and advances to unconsolidated affiliates, including approximately $238 million related to BHIG and approximately $115 million for our final investment in the JIGPC joint venture. We also invested $61.9 million in financing receivables related to a natural gas-to-syngas processing facility in Uzbekistan and paid $59.9 million, net of cash acquired, for our acquisition of an independent industrial gases company in Belgium.

Partially offsetting these uses in fiscal year 2025 were $245.8 million of cash proceeds from sales of assets and investments, which primarily included $104.3 million from the sale of a subsidiary in Singapore and $37.7 million from the sale of a regional office in Hersham, England. Maturities of short-term investments provided cash of $122.5 million, which exceeded purchases of $117.6 million.

Capital Expenditures (Non-GAAP Financial Measure)

The components of our capital expenditures are detailed in the table below. Refer to “Reconciliations of Non-GAAP Financial Measures” for a definition of this non-GAAP financial measure as well as a reconciliation to cash used for investing activities.

Fiscal Year Ended 30 September (Millions of U.S. Dollars)20262025
Additions to plant and equipment, including long-term deposits$4,203.9$7,022.6
Acquisitions, less cash acquired—59.9
Investments in and advances to unconsolidated affiliates126.8390.4
Investments in financing receivables—61.9
NGHC expenditures not funded by Air Products' equity(A)(1,024.9)(2,470.7)
Capital expenditures$3,305.8$5,064.1

(A)Reflects the portion of "Additions to plant and equipment, including long-term deposits" that is associated with NGHC, less our approximate cash investment in the joint venture. Substantially all the funding we provide to NGHC is limited for use by the joint venture for its capital expenditures. For additional information on this adjustment, refer to the reconciliation to cash used for investing activities.

Capital expenditures in fiscal year 2026 totaled $3.3 billion compared to $5.1 billion in fiscal year 2025. Capital expenditures for both periods primarily reflected investments in clean energy initiatives, including the NEOM Green Hydrogen Project and our net-zero hydrogen energy complex in Alberta, Canada, as well as ongoing capital spending to maintain and replace assets in our core industrial gases business.

Outlook for Investing Activities

It is not possible, without unreasonable efforts, to reconcile our forecasted capital expenditures to future cash used for investing activities because management is unable to identify the timing or occurrence of our future investment activity, which is driven by our assessment of competing opportunities at the time we enter into transactions. These decisions, either individually or in the aggregate, could have a significant effect on our cash used for investing activities. Accordingly, management is unable to fully reconcile, without unreasonable efforts, our forecasted capital expenditures to future cash used for investing activities.

We expect capital expenditures for fiscal year 2027 to be approximately $3.0 billion to $3.5 billion. Over $1 billion is expected to support growth in our traditional industrial gas business, with significant investment in projects serving the electronics industry. Approximately $1.5 billion is expected to support our remaining energy transition projects as they progress toward completion. Our forecast also includes ongoing maintenance spending within our core business.

We anticipate funding these expenditures through our existing cash balance and cash generated from continuing operations. We also have access to capital and money market financing as well as other sources of funding as discussed in "Financing and Capital Structure".

Cash Flows From Financing Activities

Fiscal Year Ended 30 September (Millions of U.S. Dollars)20262025
Long-term debt proceeds$827.3$4,386.7
Payments on long-term debt(686.6)(429.9)
Net increase (decrease) in commercial paper and short-term borrowings84.0(74.7)
Dividends paid to shareholders(1,603.1)(1,584.1)
Investments by noncontrolling interests353.7594.6
Distributions to noncontrolling interests(4.0)(7.2)
Other financing activities(37.5)(90.2)
Cash (Used for) Provided by Financing Activities($1,066.2)$2,795.2

In fiscal year 2026, cash used for financing activities was $1.1 billion. Uses of cash primarily included dividend payments to shareholders of $1.6 billion and long-term debt repayments of $686.6 million. Long-term debt repayments included the repayment of $550.0 million aggregate principal amount of 1.50% senior notes due October 2025. These uses were partially offset by $827.3 million of long-term debt proceeds, primarily from incremental borrowings under the project financing arrangement available to NGHC for the NEOM Green Hydrogen Project. Other sources of cash included $353.7 million from investments by noncontrolling interests, primarily related to NGHC and an $84.0 million net increase in short-term borrowings.

In fiscal year 2025, cash provided by financing activities was $2.8 billion. The primary source of cash was long-term debt proceeds of $4.4 billion, which included $2.7 billion from Euro- and U.S. Dollar-denominated senior fixed-rate notes issued in February and June 2025. Net proceeds from the notes were used to repay commercial paper obligations, including those incurred prior to the closing of the February 2025 Offering that were used to repay €300 million (approximately $311 million) aggregate principal amount outstanding of our 1.000% Euro-denominated senior fixed-rate notes at maturity, plus accrued interest, and for general corporate purposes. Long-term debt proceeds also included $1.6 billion from project financing available to NGHC. Other sources of cash included $594.6 million in contributions from noncontrolling interests, primarily related to NGHC. These sources were partially offset by dividend payments to shareholders of $1.6 billion.

Financing and Capital Structure

Debt

Total debt increased to $17.8 billion as of 30 September 2026 compared to $17.7 billion as of 30 September 2025. Total debt included related party debt of $244.0 million and $236.5 million as of 30 September 2026 and 30 September 2025, respectively.

Fiscal year 2026 borrowings primarily consisted of $740.3 million drawn under non-recourse project financing available to the NGHC joint venture. These proceeds were partially offset by the repayment of $550.0 million aggregate principal amount of 1.50% senior notes due October 2025.

Various debt agreements to which we are a party include financial covenants and other restrictions, including restrictions on our ability to create property liens and enter into certain sale and leaseback transactions. As of 30 September 2026, we were in compliance with all financial and other covenants under our debt agreements.

Committed Credit Facilities

On 26 March 2026, we amended our existing 364-day $500 million revolving credit agreement to extend its maturity date from 26 March 2026 to 25 March 2027. The amendment also provides that if we elect to convert the facility into a term loan, the maturity date of the term loan would be 25 March 2028. Fees incurred in connection with the amendment were not material.

We also maintain a five-year $3.0 billion revolving credit agreement that matures on 31 March 2029. Both the 364-day agreement and the five-year agreement are syndicated committed facilities that provide a source of liquidity and support our commercial paper program through the availability of senior unsecured debt to us and certain of our subsidiaries. No borrowings were outstanding under either of the agreements as of 30 September 2026 or 30 September 2025.

Separately, certain of our foreign subsidiaries maintain access to committed credit facilities with a combined maximum borrowing capacity of $386.0 million, all of which was borrowed and outstanding as of 30 September 2026. The amount available and borrowed as of 30 September 2025 was $394.0 million.

NEOM Green Hydrogen Project Financing

To support the NEOM Green Hydrogen Project, NGHC has access to project financing of approximately $6.1 billion, which is expected to fund about 69% of the project and is being drawn over the construction period, as well as additional credit facilities totaling approximately $500 million primarily for NGHC's working capital needs. Creditors of NGHC do not have recourse to the general credit of Air Products.

As of 30 September 2026, the joint venture had total principal borrowings of $5.7 billion compared to $4.9 billion as of 30 September 2025. The 2026 balance included $70.3 million of short-term borrowings and $109.1 million of long-term debt due within the next twelve months.

Refer to Note 3, Variable Interest Entities, to the consolidated financial statements for additional information.

Dividends

We believe that providing a consistent dividend plays a critical role in creating shareholder value. The Board of Directors determines whether to declare cash dividends on our common stock, and the timing and amount of those dividends, based on our financial condition and other factors it deems relevant. In January 2026, the Board of Directors approved a $0.02 per share increase to our quarterly dividend, raising it to $1.81 per share and marking our 44th consecutive year of dividend increases. For fiscal year 2027, maintaining our track record of increasing the dividend remains a priority, with future dividends subject to the discretion of the Board of Directors.

Dividends are paid quarterly, typically during the sixth week following the close of the fiscal quarter. In fiscal year 2026, we paid approximately $1.6 billion in dividends to shareholders. Dividends declared but unpaid as of 30 September 2026, as well as dividends subsequently declared through the date of this report, are as follows:

Declaration DateDividend Per ShareRecord DateDate Payable
22 July 2026$1.811 October 20269 November 2026
22 October 2026$1.814 January 20278 February 2027

PENSION BENEFITS

We and certain of our subsidiaries sponsor defined benefit pension plans and defined contribution plans that cover a substantial portion of our worldwide employees. The principal defined benefit pension plans are the U.S. salaried pension plan and the U.K. pension plan. These plans were closed to new participants in 2005, after which defined contribution plans were offered to new employees. For additional information, refer to Note 16, Retirement Benefits, to the consolidated financial statements.

Net Periodic Cost

The table below summarizes the components of net periodic cost for our U.S. and international defined benefit pension plans:

Fiscal Year Ended 30 September (Millions of U.S. Dollars)20262025
Service cost$19.0$20.7
Non-service related costs15.745.0
Other1.10.3
Net Periodic Cost$35.8$66.0

Net periodic cost was $35.8 million and $66.0 million in fiscal years 2026 and 2025, respectively. The lower non-service related costs are the result of higher expected return on plan assets from increases in the return assumption and a decrease in actuarial loss amortization. The net impact of non-service related items are reflected within "Other non-operating income (expense), net" on our consolidated income statements.

Service costs result from benefits earned by active employees and are reflected as operating expenses primarily within "Cost of sales" and "Selling and administrative expense" on our consolidated income statements. The amount of service costs capitalized in fiscal years 2026 and 2025 was not material.

The table below summarizes the assumptions used in the calculation of net periodic cost for the fiscal years ended 30 September:

20262025
Weighted average discount rate – Service cost5.3%4.9%
Weighted average discount rate – Interest cost4.8%4.6%
Weighted average expected rate of return on plan assets6.0%5.4%
Weighted average expected rate of compensation increase3.5%3.5%

2027 Outlook

In fiscal year 2027, we expect to recognize pension expense of approximately $30 million to $40 million, which includes approximately $15 million to $25 million of non-service related costs. The increase in non-service related costs are the result of higher interest costs and lower expected return on assets due to a smaller beginning balance of plan assets that is partially offset by lower actuarial loss amortization. Due to a decline in active participants in our U.S. salaried pension plan, actuarial losses will be amortized over the average remaining life expectancy of plan participants beginning in fiscal year 2027. This change is expected to reduce the annual actuarial loss amortization included in net periodic pension cost.

In fiscal year 2026, we recognized net actuarial gains of $18.7 million in other comprehensive income. Actuarial gains and losses are amortized into pension expense over prospective periods to the extent they are not offset by future gains or losses. Future changes in the discount rate and actual returns on plan assets could impact the actuarial gain or loss and resulting amortization in years beyond fiscal year 2027.

Pension Funding

Funded Status

The projected benefit obligation represents the actuarial present value of benefits attributable to employee service rendered to date, including the effects of estimated future salary increases. The plan funded status is calculated as the difference between the projected benefit obligation and the fair value of plan assets at the end of the period.

The table below summarizes the projected benefit obligation, the fair value of plan assets, and the funded status for our U.S. and international plans:

30 September (Millions of U.S. Dollars)20262025
Projected benefit obligation$3,412.9$3,795.3
Fair value of plan assets at end of year3,403.43,727.6
Plan Funded Status($9.5)($67.7)

The net unfunded liability of $9.5 million as of 30 September 2026 decreased $58.2 million from $67.7 million as of 30 September 2025, as the decreases to the projected benefit obligation from actuarial gains due to higher discount rates were greater than the impact of increases to the projected benefit obligation from interest cost and actual losses on plan assets.

Company Contributions

Pension funding includes both contributions to funded plans and benefit payments for unfunded plans, which are primarily non-qualified plans. With respect to funded plans, our funding policy is that contributions, combined with appreciation and earnings, will be sufficient to pay benefits without creating unnecessary surpluses.

In addition, we make contributions to satisfy all legal funding requirements while managing our capacity to benefit from tax deductions attributable to plan contributions. With the assistance of third-party actuaries, we analyze the liabilities and demographics of each plan, which help guide the level of contributions. During fiscal years 2026 and 2025, our cash contributions to funded pension plans and benefit payments for unfunded pension plans were $27.1 million and $29.9 million, respectively.

For fiscal year 2027, cash contributions to defined benefit plans are estimated to be $20 million to $30 million. The estimate is based on expected contributions to certain international plans and anticipated benefit payments for unfunded plans, which are dependent upon the timing of retirements. Actual future contributions will depend on future funding legislation, discount rates, investment performance, plan design, and various other factors.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Refer to Note 1, Basis of Presentation and Major Accounting Policies, and Note 2, New Accounting Guidance, to the consolidated financial statements for a description of our major accounting policies and information concerning the implementation and impact of new accounting guidance.

The accounting policies and estimates discussed below are those that we consider to be the most critical to understanding our financial statements because they require management's most difficult, subjective, or complex judgments, often as the result of the need to make estimates about the effects of matters that are inherently uncertain. These estimates reflect our best judgment about current and/or future economic and market conditions and their potential effects based on information available as of the date of our consolidated financial statements. If conditions change, actual results may differ materially from these estimates. Our management has reviewed these critical accounting policies and estimates and related disclosures with the Audit and Finance Committee of our Board of Directors.

Depreciable Lives of Plant and Equipment

Plant and equipment, net as of 30 September 2026 totaled approximately $25.3 billion, and depreciation expense totaled approximately $1.5 billion during fiscal year 2026. Disclosures related to plant and equipment are included in Note 9, Plant and Equipment, net, to the consolidated financial statements.

Plant and equipment is recorded at cost and depreciated using the straight-line method, which recognizes the cost of each asset on a straight-line basis over its estimated economic useful life. Economic useful life is the period over which an asset is expected to be productively employed by us, which may be less than its physical life. Factors considered in estimating useful lives include, among others: wear and tear, obsolescence, technical standards, contract life, market demand, competitive position, raw material availability, and geographic location.

The estimated economic useful life of an asset is monitored to determine its appropriateness, especially when business circumstances change. For example, changes in technology, estimated future demand for products, excessive wear and tear, or unanticipated government actions may result in a shorter estimated useful life than originally anticipated. In these cases, we would depreciate the remaining net book value over the new estimated remaining life, thereby increasing depreciation expense on a prospective basis. Likewise, if the estimated useful life is increased, depreciation expense would decrease on a prospective basis.

Our regional industrial gas segments have numerous long-term customer supply contracts for which we construct an on-site plant on or near the customer’s facility. These contracts typically have initial contract terms of 10 to 20 years. Depreciable lives of the production assets related to long-term supply contracts are generally matched to the contract lives. Extensions of these contracts frequently occur prior to expiration of the initial term. Upon extension, we reassess the estimated useful lives of the related production assets, which are generally adjusted to align with the revised contract term not to exceed the assets’ remaining physical lives.

Our regional industrial gas segments also have contracts for liquid or gaseous bulk supply and, for smaller customers, packaged gases. The depreciable lives of production facilities associated with these contracts are generally 15 years. These depreciable lives are based on historical experience and management’s judgment regarding future conditions such as technological advances, potential obsolescence, and competitors’ actions.

In addition, we may purchase assets through transactions accounted for as either asset acquisitions or business combinations. Depreciable lives are assigned to acquired assets based on the age and condition of the assets, the remaining duration of long-term supply contracts served by the assets, and our historical experience with similar assets. We reassess the estimated useful lives of these assets as circumstances change and adjust them when appropriate.

We continue to depreciate assets that are temporarily idle. Depreciation is discontinued when assets meet the criteria for classification as held for sale.

Impairment of Assets

In fiscal year 2026, we made decisions to exit certain projects as discussed in Note 4, Business and Asset Actions, to the consolidated financial statements. As a result, we assessed the recoverability of the affected project assets and, where applicable, measured impairment based on the amount by which their carrying values exceeded their estimated fair values. The resulting impairment charges are discussed under “Impairment of Assets: Plant and Equipment.”

No triggering events were identified in fiscal year 2026 that required impairment testing for any of our reporting units containing goodwill or indefinite-lived intangible assets. We completed our annual impairment assessments and concluded that no impairments were required. Refer to “Impairment of Assets: Goodwill” and “Impairment of Assets: Intangible Assets” for additional detail.

Impairment of Assets: Plant and Equipment

Plant and equipment meeting the held for sale criteria are reported at the lower of carrying amount or fair value less cost to sell. Plant and equipment to be disposed of other than by sale may be reviewed for impairment upon the occurrence of certain triggering events, such as decisions to discontinue or exit projects, unexpected contract terminations, or unforeseen foreign government-imposed restrictions or expropriations. Plant and equipment held for use are grouped for impairment testing at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. Impairment testing of the asset group occurs whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. Such circumstances may include:

  • a significant decrease in the market value of a long-lived asset group;

  • a significant adverse change in the manner in which the asset group is being used or in its physical condition;

  • an accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the long-lived asset;

  • a reduction in revenues that is other than temporary;

  • a history of operating or cash flow losses associated with the use of the asset grouping; or

  • changes in the expected useful life of the long-lived assets.

If such circumstances are determined to exist, the estimated undiscounted future cash flows expected to result from the use and eventual disposition of the asset group are compared to its carrying amount to determine whether the asset group is recoverable. If an asset group is determined to be impaired, the loss is measured as the difference between the asset group’s fair value and its carrying amount. Fair value is estimated using valuation techniques appropriate to the facts and circumstances, which may include discounted cash flows or estimates of proceeds from the sale or other disposition of the assets.

The assumptions underlying the undiscounted future cash flow projections require significant management judgment. Factors that management considers include, but are not limited to, industry and market conditions, sales volumes and prices, costs to produce, and inflation. The assumptions underlying the cash flow projections represent management’s best estimates at the time of the impairment review and may include probability weighting of cash flow projections associated with multiple potential future scenarios. Our impairment reviews are based on assumptions that reflect information available at the time; however, changes in key assumptions or actual conditions that differ from our estimates could result in additional impairment charges.

In connection with the project exit decisions discussed in Note 4, Business and Asset Actions, to the consolidated financial statements, we assessed the recoverability of certain project assets and recorded impairment charges of approximately $2.2 billion in fiscal year 2026. The impairment charges were measured as the amount by which the carrying amount of the affected plant and equipment exceeded its estimated fair value. Because observable market prices were not available, the related fair value estimates reflected expected proceeds from the sale or other disposition of the assets, considering their condition, location, and available market information. As of 30 September 2026, the estimated fair value of plant and equipment expected to be sold or otherwise disposed of was $233.9 million.

In addition, following initial impairment charges recognized in fiscal year 2025, changes in facts and circumstances in fiscal year 2026 resulted in updated fair value measurements and additional impairment charges of $206.3 million related to plant and equipment associated with two China gasification plants. For one plant, the fair value estimate was developed using information obtained through the marketing process. Significant unobservable inputs included the likelihood of completing a sale and the amount of proceeds that could be obtained based on the limited level of buyer interest. These inputs supported a significantly lower fair value estimate, and we fully impaired the remaining plant and equipment. Any potential recovery related to this disposal group will be recognized in the period in which the applicable recognition criteria are met. For the other plant, we estimated fair value less costs to sell based on the terms of a definitive sales agreement executed on 1 October 2026. The measurement was based on the fixed consideration provided for in the agreement, adjusted for estimated costs to sell. The impairment charge was measured as the amount by which the carrying amount of the assets exceeded their estimated fair value less costs to sell. As of 30 September 2026, the estimated fair value of the plant and equipment associated with this plant was $261.2 million and was presented within "Assets held for sale" on our consolidated balance sheet.

These estimates were considered critical because they involved significant assumptions regarding future cash flows, expected disposition proceeds, asset disposition strategies, and market conditions, including available market information and the level of buyer interest. Additionally, certain project exit activities remain ongoing, including efforts to sell, redeploy, or otherwise dispose of the affected assets. Changes in the intended use or disposition of these assets, or further project-related decisions, could affect their recoverability or estimated fair value and result in additional impairment charges or adjustments to previously recognized impairment charges in future periods.

Other than the impairment charges discussed above, no additional asset groups required impairment testing during fiscal year 2026, as no other events or changes in circumstances indicated that their carrying amounts may not be recoverable.

Impairment of Assets: Goodwill

The acquisition method of accounting for business combinations requires us to use estimates and judgments to allocate the purchase price of an acquired business to the fair value of its net tangible and identifiable intangible assets. Goodwill represents the excess of the aggregate purchase price, plus the fair value of any noncontrolling interest and previously held equity interest in the acquiree, over the fair value of the identifiable net assets acquired. Goodwill, net was $948.6 million as of 30 September 2026. Disclosures related to goodwill are included in Note 10, Goodwill, to the consolidated financial statements.

We review goodwill for impairment annually in the fourth quarter of the fiscal year and whenever events or changes in circumstances indicate that it is more likely than not that the fair value of a reporting unit is less than its carrying value. The impairment test is performed at the reporting unit level, which is defined as an operating segment or one level below an operating segment for which discrete financial information is available and whose operating results are regularly reviewed by segment management. At the time of our fiscal year 2026 testing, we had five reportable business segments, six operating segments, and 10 reporting units, eight of which had a goodwill balance. Reporting units are primarily based on products and subregions within each reportable segment. The majority of our goodwill is assigned to reporting units within our regional industrial gases segments. Refer to Note 24, Business Segment and Geographic Information, for additional information.

As part of our annual goodwill impairment testing, we have the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. Our qualitative evaluation considers relevant facts, events, and circumstances affecting a reporting unit, including, but not limited to: business performance, strategy, and outlook; macroeconomic conditions; local market dynamics; cost management; and significant changes in key personnel, customers, operating assets, or product mix. We perform a quantitative test when qualitative factors alone are not sufficient to conclude whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. We may also elect to bypass the qualitative assessment and proceed directly to the quantitative test. If we perform a quantitative test, an impairment loss is recognized for the amount by which the carrying value of the reporting unit exceeds its fair value, not to exceed the total amount of goodwill allocated to that reporting unit.

In the fourth quarter of fiscal year 2026, we performed our annual goodwill impairment test and concluded that it was more likely than not that the fair value of each reporting unit was greater than its carrying value.

Impairment of Assets: Intangible Assets

Disclosures related to intangible assets other than goodwill are included in Note 11, Intangible Assets, to the consolidated financial statements.

Intangible assets, net with determinable lives as of 30 September 2026 totaled $226.3 million and consisted primarily of customer relationships. Finite-lived intangible assets are tested for impairment as part of the long-lived asset group impairment tests. Impairment testing of an asset group is performed whenever events or changes in circumstances indicate that its carrying value may not be recoverable. See the impairment discussion above under "Impairment of Assets: Plant and Equipment" for a description of how impairment losses are determined.

Indefinite-lived intangible assets as of 30 September 2026 totaled $36.4 million and consisted of trade names and trademarks. Indefinite-lived intangibles are subject to impairment testing at least annually or more frequently if events or changes in circumstances indicate that it is more likely than not that the asset is impaired. As part of our annual indefinite-lived intangible asset impairment testing, we have the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of the intangible asset is less than its carrying value. Our evaluation of qualitative factors considers relevant facts, events, and circumstances including, but not limited to: business performance, strategy and outlook; macroeconomic conditions; local market dynamics; and significant changes in key personnel, customers, operating assets, or product mix. We perform a quantitative test when qualitative factors alone are not sufficient to conclude whether it is more likely than not that the fair value of the intangible asset is less than its carrying value. If we perform a quantitative test, an impairment loss is recognized for the amount by which the carrying value of the indefinite-lived intangible asset exceeds its fair value, not to exceed the carrying value of the asset.

In the fourth quarter of fiscal year 2026, we performed our annual indefinite-lived intangible asset impairment assessment and concluded that it was more likely than not that the fair value of each asset was greater than its carrying value.

Impairment of Assets: Equity Method Investments

Investments in net assets of and advances to equity affiliates totaled approximately $5.7 billion as of 30 September 2026. All of our equity method investments are foreign affiliates, the majority of which are ventures with other industrial gas companies. Summarized financial information for our equity affiliates is included in Note 8, Equity Affiliates, to the consolidated financial statements.

We review our equity method investments for impairment whenever events or changes in circumstances indicate that a loss in value of an investment may have occurred. An impairment loss is recognized when a decline in fair value below the carrying amount of an investment is determined to be other than temporary. We estimate the fair value of our investments using the income approach, which considers the estimated discounted future cash flows expected to be generated by the investee, and/or the market approach, which considers market multiples of revenue and earnings derived from comparable publicly-traded industrial gas companies. Changes in key assumptions about the financial condition of an investee or actual conditions that differ from our estimates could result in an impairment charge.

In connection with certain project exit decisions, we recorded impairment charges related to equity method investments of $2.0 million in fiscal year 2026. Additional information regarding these project exit decisions is provided in Note 4, Business and Asset Actions, to the consolidated financial statements. In fiscal year 2026, there were no other events or changes in circumstances that indicated an other-than-temporary loss in value of our equity method investments.

Revenue Recognition: Cost Incurred Input Method

Revenue from sale of equipment contracts is generally recognized over time as we have an enforceable right to payment for performance completed to date and our performance under the contract terms does not create an asset with alternative use. We use a cost incurred input method under which costs incurred to date relative to total estimated costs at completion are used to measure progress toward satisfying performance obligations. Costs incurred include material, labor, and overhead costs and represent work that contributes proportionately to the transfer of control to the customer.

Accounting for contracts using the cost incurred input method requires management judgment in estimating total contract revenues and costs and assessing the risks that may affect those estimates. Our estimates are impacted by factors such as the potential for incentives or penalties on performance, schedule delays, technical issues, cost inflation, labor productivity, the complexity of work performed, the availability of materials, and performance of subcontractors. When adjustments to estimated total contract revenues or estimated total costs are required, changes in estimated profit from prior estimates are recognized in the current period based on the inception-to-date effect of the change. When estimates of total costs to be incurred on a contract exceed estimates of total revenues to be earned, a provision for the entire estimated loss on the contract is recorded in the period in which the loss is determined.

In addition to the typical risks associated with the performance of engineering, project procurement, and construction activities, our sale of equipment projects within our Corporate and other segment require judgment in monitoring risks associated with schedule, geography, and other aspects of the contract and their effects on our estimates of total revenues and total costs to complete the contract.

We assess the performance of our sale of equipment projects as they progress. Our earnings could be positively or negatively impacted by changes to our contractual revenue and cost forecasts on these projects. Changes to project revenue and cost estimates unfavorably impacted operating results by approximately $90 million in fiscal year 2026.

Revenue Recognition: On-site Customer Contracts

For customers who require large volumes of gases on a long-term basis, we produce and supply gases under long-term contracts from large facilities that we build, own, and operate on or near the customer’s facilities. Certain of these on-site contracts contain complex terms and provisions regarding tolling arrangements, minimum payment requirements, variable components, pricing provisions, and amendments, which require significant judgment to determine the amount and timing of revenue recognition.

Income Taxes

We account for income taxes under the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the tax effects of temporary differences between the financial reporting and tax basis of assets and liabilities measured using enacted tax rates in effect for the year in which the differences are expected to be recovered or settled. As of 30 September 2026, accrued income taxes were $114.1 million, and our net deferred income tax liability was $52.2 million. Unrecognized tax benefits as of 30 September 2026 were $188.5 million, excluding interest and penalties. Income tax expense for the fiscal year ended 30 September 2026 was $1.6 million.

Management judgment is required in estimating our tax liabilities, including those associated with uncertain tax positions, and assessing the realizability of deferred tax assets. These estimates are subject to uncertainty because they depend on the interpretation of complex tax laws and regulations, the outcome of examinations by taxing authorities, and assumptions regarding future taxable income.

Actual income taxes paid may vary from estimates, depending upon changes in income tax laws, actual results of operations, and the final audit of tax returns by taxing authorities. Tax assessments may arise several years after tax returns have been filed. We believe that our recorded tax liabilities adequately provide for these assessments.

Deferred tax assets are recorded for operating losses and tax credit carryforwards. However, when we do not expect sufficient sources of future taxable income to realize the benefit of the operating losses or tax credit carryforwards, these deferred tax assets are reduced by a valuation allowance. A valuation allowance is recognized if, based on the weight of available evidence, it is considered more likely than not that some portion or all of the deferred tax asset will not be realized. The factors used to assess the likelihood of realization include forecasted future taxable income and available tax planning strategies that could be implemented to realize or renew net deferred tax assets in order to avoid the potential loss of future tax benefits. Our assessment requires significant judgment because the amount of future taxable income may be affected by changes in our operating results, the timing and nature of taxable income in individual jurisdictions, and changes in tax laws. Changes in these factors could result in an increase or decrease in the valuation allowance. The effect of a change in the valuation allowance is reported in income tax expense.

A 1% increase or decrease in our effective tax rate would result, assuming no change in income before taxes, in a decrease or increase to net income, respectively, of approximately $6 million.

Disclosures related to income taxes are included in Note 22, Income Taxes, to the consolidated financial statements.

Pension and Other Postretirement Benefits

The amounts recognized in the consolidated financial statements for pension and other postretirement benefits are determined on an actuarial basis utilizing numerous assumptions. The discussion that follows provides information on the significant assumptions, expense, and obligations associated with the defined benefit plans.

Actuarial models are used in calculating the expense and liability related to the various defined benefit plans. These models have an underlying assumption that the employees render service over their service lives on a relatively consistent basis; therefore, the expense of benefits earned should follow a similar pattern.

Several assumptions and statistical variables are used in the models to calculate the expense and liability related to the plans. We determine assumptions about the discount rate, the expected rate of return on plan assets, and the rate of compensation increase. Note 16, Retirement Benefits, to the consolidated financial statements includes disclosure of these rates on a weighted-average basis for both the U.S. and international plans. The actuarial models also use assumptions about demographic factors such as retirement age, mortality, and turnover rates. Mortality rates are based on the most recent U.S. and international mortality tables. We believe the actuarial assumptions are reasonable. However, actual results could vary materially from these actuarial assumptions due to economic events and differences in rates of retirement, mortality, and turnover.

One of the assumptions used in the actuarial models is the discount rate used to measure benefit obligations. This rate reflects the prevailing market rate for high-quality, fixed-income debt instruments with maturities corresponding to the expected timing of benefit payments as of the annual measurement date for each of the various plans. We measure the service cost and interest cost components of pension expense by applying spot rates along the yield curve to the relevant projected cash flows. The rates along the yield curve are used to discount the future cash flows of benefit obligations back to the measurement date. These rates change from year to year based on market conditions that affect corporate bond yields. A higher discount rate decreases the present value of the benefit obligations and results in lower pension expense. With respect to impacts on pension benefit obligations, a 50 bp increase or decrease in the discount rate may result in a decrease or increase, respectively, to pension expense of approximately $11 million per year.

The expected rate of return on plan assets represents an estimate of the long-term average rate of return to be earned by plan assets reflecting current asset allocations. In determining estimated asset class returns, we take into account historical and future expected long-term returns and the value of active management, as well as the interest rate environment. Asset allocation is determined based on long-term return, volatility and correlation characteristics of the asset classes, the profiles of the plans’ liabilities, and acceptable levels of risk. Lower returns on the plan assets result in higher pension expense. A 50 bp increase or decrease in the estimated rate of return on plan assets may result in a decrease or increase, respectively, to pension expense of approximately $18 million per year.

We use a market-related valuation method for recognizing certain investment gains or losses for our significant pension plans. Investment gains or losses are the difference between the expected return and actual return on plan assets. The expected return on plan assets is determined based on a market-related value of plan assets. This is a calculated value that recognizes investment gains and losses on equities over a five-year period from the year in which they occur and reduces year-to-year volatility. The market-related value for non-equity investments equals the actual fair value. Expense in future periods will be impacted as gains or losses are recognized in the market-related value of assets.

The expected rate of compensation increase is another key assumption. We determine this rate based on review of the underlying long-term salary increase trend characteristic of labor markets and historical experience, as well as comparison to peer companies. A 50 bp increase or decrease in the expected rate of compensation may result in an increase or decrease to pension expense, respectively, of approximately $3 million per year.

Loss Contingencies

In the normal course of business, we encounter various contingencies that involve uncertainty as to their ultimate resolution and potential impact on our financial statements. Our loss contingencies primarily include litigation and environmental matters. Additional information is provided in Note 17, Commitments and Contingencies, to the consolidated financial statements.

We accrue a liability for loss contingencies when we determine it is probable that a loss has been incurred and the amount can be reasonably estimated. When a range of possible loss can be reasonably estimated, the most probable amount in the range is accrued. If no amount within the range is a better estimate than any other, the minimum amount is accrued.

Significant judgment is required to evaluate the likelihood of an unfavorable outcome and determine whether the amount or range of potential loss can be reasonably estimated. These determinations are based on the information available at the time, including the status of proceedings, relevant laws and regulations, opinions of legal counsel, and our experience with similar matters, as applicable. As additional information becomes available, we reassess our conclusions and estimates. Changes in these judgments and estimates could result in the recognition or adjustment of a liability and could materially affect our results of operations in the period in which the change occurs.

For example, due to the inherent uncertainties in estimating environmental exposures, our estimates could change significantly if a new site is designated, the scope of remediation is increased, a different remediation alternative is identified, or our proportionate share of the liability increases. Similarly, changes in our estimates of regulatory fines or damage awards associated with litigation could have a significant impact on our net income in the period in which an accrual is recorded or adjusted.

Previous: Item 6. [Reserved] · Next: Item 7A. Quantitative and Qualitative Disclosures About Market Risk